Skip to main content
TipRanks
Go Ultimate75% OFF

Core Laboratories (CEI) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Core Laboratories has a market cap or net worth of CHF 325.54M. The enterprise value is CHF 599.81M.

Market Cap
CHF 325.54M
Enterprise Value
CHF 599.81M

Share Statistics

Core Laboratories has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
―
Owned by Insiders
1.17%
Owned by Institutions
64.94%

Financial Efficiency

Core Laboratories’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.83%.

Return on Equity (ROE)
0.11
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
6.83%
Return on Capital Employed (ROCE)
0.11
Revenue Per Employee
159.55K
Profits Per Employee
8,990.606
Employee Count
3,300
Asset Turnover
0.90
Inventory Turnover
7.93

Valuation Ratios

The current PE Ratio of Core Laboratories is 25.10. Core Laboratories’s PEG ratio is -0.50.

PE Ratio
25.10
PS Ratio
0.76
PB Ratio
1.43
Price to FCF
18.72
Price to Operating Cash Flow
16.15
PEG Ratio
-0.50

Income Statement

In the last 12 months, Core Laboratories had revenue of 526.52M and earned 29.67M in profits. Earnings per share was 0.68.

Revenue
526.52M
Gross Profit
94.28M
Operating Income
50.49M
Pretax Income
45.90M
Net Income
29.67M
EBITDA
71.12M
Earnings Per Share (EPS)
0.68

Cash Flow

In the last 12 months, operating cash flow was 24.69M and capital expenditures -3.80M, giving a free cash flow of 20.89M billion.

Operating Cash Flow
24.69M
Free Cash Flow
20.89M
Free Cash Flow per Share
0.45

Dividends & Yields

Core Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
5.35%
Earnings Yield
3.91%

Important Dates

Core Laboratories upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 28, 2026
Next Earnings Date
Feb 03, 2027
Ex-Dividend Date
―

Financial Position

Core Laboratories as a current ratio of 2.02, with Debt / Equity ratio of 61.66%

Current Ratio
2.02
Quick Ratio
1.51
Debt to Market Cap
0.15
Net Debt to EBITDA
1.99
Interest Coverage Ratio
4.78

Taxes

In the past 12 months, Core Laboratories has paid 15.51M in taxes.

Income Tax
15.51M
Effective Tax Rate
0.34

Enterprise Valuation

Core Laboratories EV to EBITDA ratio is 9.85, with an EV/FCF ratio of 25.42.

EV to Sales
1.03
EV to EBITDA
9.85
EV to Free Cash Flow
25.42
EV to Operating Cash Flow
21.51

Balance Sheet

Core Laboratories has CHF 21.38M in cash and marketable securities with CHF 161.97M in debt, giving a net cash position of -CHF 140.59M billion.

Cash & Marketable Securities
CHF 21.38M
Total Debt
CHF 161.97M
Net Cash
-CHF 140.59M
Net Cash Per Share
―
Tangible Book Value Per Share
CHF 3.67

Margins

Gross margin is 17.67%, with operating margin of 7.57%, and net profit margin of 3.01%.

Gross Margin
17.67%
Operating Margin
7.57%
Pretax Margin
5.38%
Net Profit Margin
3.01%
EBITDA Margin
10.43%
EBIT Margin
7.52%

Analyst Forecast

The average price target for Core Laboratories is CHF 9.25, which is 11.43% higher than the current price. The consensus rating is Moderate Sell

Price Target
CHF 9.25
Price Target Upside
―
Analyst Consensus
Moderate Sell
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
―

Scores

Smart Score
2
AI Score
―